Ginkgo Bioworks Holdings, Inc.
DNA
$7.71
-$0.14-1.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.27% | 0.00% | -33.92% | 33.70% | 15.42% |
| Total Depreciation and Amortization | -4.06% | 5,235.12% | -99.18% | 92.93% | -3.01% |
| Total Amortization of Deferred Charges | -10.64% | -66.43% | 397.87% | -211.90% | -10.64% |
| Total Other Non-Cash Items | -13.30% | 102.78% | -21.37% | -14.30% | -33.43% |
| Change in Net Operating Assets | 39.89% | -271.21% | 160.66% | -231.53% | -414.41% |
| Cash from Operations | 2.08% | -50.85% | 21.48% | 21.87% | -21.41% |
| Capital Expenditure | -38,560.00% | -- | 100.00% | 99.50% | 44.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -73.48% | 229.82% | -14.04% | 66.58% | -33,737.68% |
| Cash from Investing | -75.68% | 230.60% | -13.97% | 67.84% | -1,418.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 24.00% | -4.17% | 75.51% | 52.66% | -1.97% |
| Issuance of Common Stock | -- | -11.29% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -177.46% | -- | -- | -- |
| Cash from Financing | -100.23% | -18.07% | 10,240.82% | 52.66% | -1.97% |
| Foreign Exchange rate Adjustments | 15.13% | -263.44% | -50.00% | 151.35% | 201.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.77% | 158.70% | 9.29% | 58.43% | -348.67% |